PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target

Surgery (United States)

Volumn 154, Issue 6, 2013, Pages 1405-1416

  Demeure, Michael J ^a   Coan, Kathryn E ^b   Grant, Clive S ^c   Komorowski, Richard A ^d   Stephan, Elizabeth ^a   Sinari, Shripad ^a   Mount, David ^e   Bussey, Kimberly J ^a  

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CYCLIN DEPENDENT KINASE; PROTEIN P53; SECURIN; VORINOSTAT;

ADRENAL CORTEX CARCINOMA; ADULT; AGED; ARTICLE; CANCER INHIBITION; CANCER PROGNOSIS; CANCER SURVIVAL; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; M PHASE CELL CYCLE CHECKPOINT; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION; HUMANS; HYDROXAMIC ACIDS; MALE; MIDDLE AGED; PROGNOSIS; SECURIN; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 84887862703     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2013.06.058     Document Type: Article

References (25)

1. K.Y. Bilimoria, W.T. Shen, D. Elaraj, D.J. Bentrem, D.J. Winchester, and E. Kebebew Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors Cancer 113 2008 3130 3136
2. M.J. Demeure, and L.B. Somberg Functioning and nonfunctioning adrenocortical carcinoma Surg Oncol Clin North Am 7 1998 791 805
3. M. Terzolo, and A. Berruti Adjunctive treatment of adrenocortical carcinoma Curr Opin Endocrrinol Diabetes Obes 15 2008 221 226
4. M. Fassnacht, M. Terzolo, B. Allolio, E. Baudin, H. Haak, and A. Berruti Combination chemotherapy in advanced adrenocortical carcinoma N Engl J Med 366 2012 2189 2197
5. F. de Fraipont, M. El Atifi, N. Cherradi, G. Le Moigne, G. Defaye, and R. Houlgatte Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy J Clin Endocrinol Metab 90 2005 1819 1829
6. A. de Reyniès, G. Assie, D.S. Rickman, F. Tissier, L. Groussin, and F. Rene-Corail Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival J Clin Oncol 27 2009 1108 1115
7. T.J. Giordano, R. Kuick, T. Else, P.G. Gauger, M. Vinco, and J. Bauersfeld Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling Clin Cancer Res 15 2009 668 676
8. D. Velazquez-Fernandez, C. Laurell, J. Geli, A. Hoog, J. Odeberg, and M. Kjellman Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy Surgery 138 2005 1087 1094
9. M. Fassnacht, S. Johanssen, M. Quinkler, P. Bucsky, H.S. Willenberg, and F. Beuschlein Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification Cancer 115 2009 243 250
10. L.M. Weiss Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors Am J Surg Pathol 8 1984 163 169
11. M. Reich, T. Liefeld, J. Gould, J. Lerner, P. Tamayo, and J.P. Mesirov GenePattern 2.0 Nat Genet 38 2006 500 501
12. R.A. Irizarry, B. Hobbs, F. Collin, Y.D. Beazer-Barclay, K.J. Antonellis, and U. Scherf Exploration, normalization, and summaries of high density oligonucleotide array probe level data Biostatistics 4 2003 249 264
13. W.E. Johnson, C. Li, and A. Rabinovic Adjusting batch effects in microarray expression data using empirical Bayes methods Biostatistics 8 2007 118 127
14. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 29 2001 e45
15. A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, and M.A. Gillette Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc Natl Acad Sci U S A 102 2005 15545 15550
16. S.L. Carter, A.C. Eklund, I.S. Kohane, L.N. Harris, and Z. Szallasi A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers Nat Genet 38 2006 1043 1048
17. A. Hernandez, G. Lopez-Lluch, P. Navas, and J.A. Pintor-Toro HDAC and Hsp90 inhibitors down-regulate PTTG1/securin but do not induce aneuploidy Genes Chromosomes Cancer 48 2009 194 201
18. Y. Tong, and T. Eigler Transcriptional targets for pituitary tumor-transforming gene-1 J Mol Endocrinol 43 2009 179 185
19. A.P. Heaney, R. Singson, C.J. McCabe, V. Nelson, M. Nakashima, and S. Melmed Expression of pituitary-tumour transforming gene in colorectal tumours Lancet 355 2000 716 719
20. S. Yan, C. Zhou, and X. Lou PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma Cancer Res 69 2009 3283 3290
21. J.A. Bernal, R. Luna, A. Espina, I. Lazaro, F. Ramos-Morales, and F. Romero Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis Nat Genet 32 2002 306 311
22. J.A. Bernal, M. Roche, C. Mendez-Vidal, A. Espina, M. Tortolero, and J.A. Pintor-Toro Proliferative potential after DNA damage and non-homologous end joining are affected by loss of securin Cell Death Differ 15 2008 202 212
23. Y. Tong, Y. Tan, C. Zhou, and S. Melmed Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition Oncogene 26 2007 5596 5605
24. L. Pei Identification of c-myc as a down-stream target for pituitary tumor-transforming gene J Biol Chem 276 2001 8484 8491
25. J. Cho-Rok, J. Yoo, Y.J. Jang, S. Kim, I.S. Chu, and Y.I. Yeom Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo Hepatology 43 2006 1042 1052